Re-audit on the management of pancreatitis at a district-general-hospital  by Bretherton, Christopher et al.
Abstracts / International Journal of Surgery 11 (2013) 589e685 641
ABSTRACTSprotection. Development of new appliance for dental protection is
required, with the aim to minimise iatrogenic injury and maximise
endoscopic outcomes.HEPATOPANCREATOBILIARY
0060: PREOPERATIVE EVALUATION OF PATIENTS WITH POTENTIALLY
RESECTABLE HILAR CHOLANGIOCARCINOMA
C.H. Tang, J.S. Hammond, A. Brooks, I.J. Beckingham, I.C. Cameron.
Nottingham Digestive Diseases Centre NIHR Biomedical Research Unit,
Nottingham, UK.
Background: preoperative evaluation of patients with hilar chol-
angiocarcinoma is a frequent source of morbidity that may preclude pa-
tient from undergoing curative resection. This study set out to determine
the morbidity associated with preoperative evaluation of patients with
potentially resectable hilar cholagiocarcinoma referred to our institution.
Methods: A retrospective review of all patients referred to our institution
over a 12 month period was performed. All patients were discussed in the
regional liver case conference. Demographics, imaging, interventions and
complications (Clavien-Dindo) were recorded.
Results: 20 patients (median age 66.5, interquartile range 15, M:F ¼ 1.2:1)
with potentially resectable hilar cholagiocarcinomawere referred between
January 2011 and December2011. Preoperative investigations included
percutaneous transhepatic cholangiography (45%), internal/external
biliary drainage (55%) and endoscopic retrograde cholangiopancreatog-
raphy (45%) and laparoscopy (25%). There were 3 grade I, 7 grade IIa and 3
grade IIb complications. The most common were sepsis (50%) and renal
failure (15%). There were no deaths.
Conclusion: Preoperative evaluation of patients with potentially resect-
able hilar cholangiocarinoma is a major source of morbidity. Future studies
will evaluate the impact of a fast track pathway.
0183: EARLY CT EVALUATION IN ACUTE PANCREATITIS: A COMPLETE
AUDIT CYCLE
N.L. Newlands 1, R. Mandavia 2, S. Rowland 2, H. Sheth 3. 1North West
Thames Foundation School, London, UK; 2Academic Surgery, North West
Thames Foundation School, London, UK; 3 Ealing Hospital NHS Trust, Uxbridge
Road, Southall UB1 3HW, UK.
Aim: Current consensus is that contrast-enhanced computer-tomography
(CE-CT) performed within 4 days of the onset of acute pancreatitis neither
predicts disease severity nor alters management. Early CE-CT is therefore
not routinely advocated unless used to exclude other intra-abdominal
pathology or early complications. The day of CE-CT, indication for CE-CT
and effect on clinical management were investigated at our institution
before and after an update of local policy to bring practice in line with
current guidelines.
Method: Data were collected before and after the intervention. Compari-
sons of the day of CE-CT, indication on CE-CT request forms and impact on
management were made between the two cohorts.
Results: 67% of patients underwent early CE-CT in the initial cycle
compared to 38% in the re-audit. The mean day of CE-CT was signiﬁcantly
later in the second cycle (p¼0.02). Following intervention early CE-CTs
requested to conﬁrm a diagnosis of acute pancreatitis decreased from 35%
to 0%. Of all CE-CTs requested those that did not altermanagement reduced
from 84% to 18%.
Conclusions: The intervention resulted in a substantial reduction in the
number of early CE-CTs performed in acute pancreatitis without clinical
rationale, reﬂecting current guidelines.
0314: SELECTIVE HEPATIC ARTERY EMBOLISATION FOR THE TREAT-
MENT OF LIVER METASTASES FROM NEURO-ENDOCRINE DISEASE
Abigail Vallance, Colin Wilson, Gay Bernstone, John Rose, Robert Williams,
Ralph Jackson, Petros Perros, Andy James, Jeremy French, Derek Manas.
Freeman Hospital, Newcastle Upon Tyne, UK.
Aim: At our institution selective hepatic artery embolisation (HAE) is
offered to symptomatic patients with hepatic gastroenteropancreatic
(GEP) neuroendocrine metastases. We aimed to assess the effectiveness of
HAE in neuroendocrine tumour and to establish any parameters which
may predict a response to treatment.Methods: We reviewed the demographics, disease distribution and
response to treatment of patients with GEP hepatic metastases undergoing
HAE from 2008-2012. Response to treatment was evaluated biochemically
(reduction in urine 5-HIAA), radiologically (contrast CT) and clinically
(patient reported symptoms).
Results: 64 procedures (range 1-7) were performed in 31 patients. 97% of
patients were receiving pre-operative somatostatin analogue treatment.
48% had an identiﬁed small bowel primary and 87% had >5 hepatic me-
tastases. A biochemical, radiological or clinical response was reported in
61%, 62% and 65% respectively. 86% of patients had a response in at least
one domainwhilst 13% had progression in all domains. 29% had procedure
related complications and no patients died within 30 days of procedure.
We could not identify any speciﬁc pre-procedural factors predictive of
response.
Conclusions: HAE is a relatively well tolerated procedure and can reduce
symptoms as well as biochemical and radiological markers of disease for
patients with hepatic GEP neuroendocrine metastases.
0390: RE-AUDIT ON THE MANAGEMENT OF PANCREATITIS AT A DIS-
TRICT-GENERAL-HOSPITAL
Christopher Bretherton, Humza Osmani, David Stoker. North Middlesex
University Hospital, London, UK.
Aim: The BSG have a number of audit standards with respect to the
management of acute pancreatitis. Our objectives were that all patients
should: 1) receive a gallbladder USS within 24 hours of admission 2) be
severity scored on admission 3) have ERCP if fulﬁlling criteria 4) have
Laparoscopic cholecystectomy booked before discharge for those with
Gallstone Pancreatitis.
Methods: Retrospective analysis of patients between April 2011 and April
2012. An early morning Ultrasound slot for surgical patients was intro-
duced in January 2012 and a management proforma created in April 2012.
Prospective data was collected from April 2012 - December 2012.
Results: > 165 cases between April 2011 and December 2012. Delay in
USS of >24 hours reduced from 26% (April 2011-January 2012) to 4%
(January 2012- July 2012) following introduction of USS slot; further
reduction to 3% also demonstrated (July 2012- December 2012). Following
introduction of proforma: 100% (77% pre-proforma) of those fulﬁlling
criteria received an ERCP (not sustained on re-audit), and a sustained
100% of patients had laparoscopic cholecystectomy booked on discharge
(85% pre- proforma). Severity stratiﬁcation documentation remained
poor.
Conclusion: Compliance with BSG guidelines can improve by introducing
a dedicated early morning surgical ultrasound slot.
0490: COMPARATIVE ASSESSMENT OF SURGICAL MEANS OF THE
BILIARY DECOMPRESSION AT PATIENTS WITH THE CRITICAL AND UN-
CRITICAL FORMS OF THE NONNEOPLASTIC OBTURATIVE JAUNDICE
Andrii Klimas, Sergii Savoliyk, Arcadii Godlevsky. Vinnitsa National Medical
University, Vinnitsa, Ukraine.
Introduction: Unsatisfactory results of the early postoperative period of
surgical treatment of the nonneoplastic obturative jaundices (NPOJ) are
speciﬁed with the postdecomprssive development and progression of the
hepatic failure on the basis of systemic metabolic malfunctions.
Aim: assessment of inﬂuence of surgical means of the billiary decom-
pression on the systemic metabolic malfunctions and the risk of post-
operative complications at the patients with critical and uncritical NPOJ for
the choice of optimal surgical tactic and principles of postoperative
intensive therapy.
Materials and Methods: The results of surgical treatment of 510 patients
with NPOJ were analyzed. The changes of the endotoxicosis and the
functional condition of the liver were made under the impact of biliary
decompression methods: external laparotomic undosed, internal: biliary-
enteric anastomosis with the duodenum, with the small intestine and
combined external-internal. External laparoscopic measured: EPST with
the nasobiliary drainage, laparoscopic cholangiostomy, PTMS.
Conclusions: The dosage of laparoscopic cholangiostomy and PTMS
decrease the risk of HF and the using of EPST with the nasobiliary drainage,
is accompanied with the risk decreasing and number of postoperative
complications. Internal decompressionwith theway of combinedmethods
is priority in the radical treatment choice of NPOJ.
